| Segment Reporting [Text Block] |
Note 13. Reportable Segments
The Company has two reportable segments: (i) e-Commerce Operations, which involves acquiring and leasing, primarily an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses and (ii) Healthcare Operations, which provides TPA, data management, prescription pharmaceuticals, compounded medications, telepharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities and contracted fulfillment facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program, and health practice risk management. This organizational structure aligns with how the Company’s CODMs manage the business, including resource allocation and performance assessment, and further aligns with the Company’s product categories and the key markets the Company serves.
The CODMs include the Company’s Chief Executive Officer and Chief Financial Officer.
The CODMs evaluate segment performance based on several factors, including Operating profit or loss, as a measure of operating segment performance which excludes the impact of Corporate overhead expenses. Corporate overhead expenses consist of executive compensation, stock-based compensation, public company expenses, and depreciation. The CODMs do not review segment assets at a level different than what is reported in the Company’s Condensed Consolidated Balance Sheets. While the Company believes there are synergies between the two business segments, the segments are managed separately because each requires different business strategies. Accounting policies associated with our operating segments are generally the same as those described in Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2025.
The following tables present a summary of the reportable segments (in thousands):
| For the Three Months Ended June 30, 2026 | | e-Commerce Operations | | | Healthcare Operations | | | Total | |
| e-Commerce revenue | | $ | 4,078 | | | $ | — | | | $ | 4,078 | |
| Pharmacy prescription and other revenue, net of PBM fees | | | — | | | | 5,564 | | | | 5,564 | |
| Pharmacy contract revenue | | | — | | | | 2,239 | | | | 2,239 | |
| Revenues, net | | | 4,078 | | | | 7,803 | | | | 11,881 | |
| | | | | | | | | | | | | |
| Segment expenses: | | | | | | | | | | | | |
| Cost of revenue | | | 2,997 | | | | 4,190 | | | | 7,187 | |
| Selling, general and administrative | | | 500 | | | | 930 | | | | 1,430 | |
| Salaries, wages and payroll taxes | | | 343 | | | | 1,638 | | | | 1,981 | |
| Depreciation and amortization | | | 12 | | | | 35 | | | | 47 | |
| Intangible asset amortization | | | 26 | | | | — | | | | 26 | |
| Total segment expenses | | | 3,878 | | | | 6,793 | | | | 10,671 | |
| Segment operating income | | $ | 200 | | | $ | 1,010 | | | | 1,210 | |
| Corporate overhead expenses | | | | | | | | | | | 1,337 | |
| Non-operating income | | | | | | | | | | | (31 | ) |
| Loss before income taxes | | | | | | | | | | | (96 | ) |
| Income taxes | | | | | | | | | | | (48 | ) |
| Net loss | | | | | | | | | | $ | (144 | ) |
| For the Three Months Ended June 30, 2025 | | e-Commerce Operations | | | Healthcare Operations | | | Total | |
| e-Commerce revenue | | $ | 4,120 | | | $ | — | | | $ | 4,120 | |
| Pharmacy prescription and other revenue, net of PBM fees | | | — | | | | 8,173 | | | | 8,173 | |
| Pharmacy contract revenue | | | — | | | | 947 | | | | 947 | |
| Revenues, net | | | 4,120 | | | | 9,120 | | | | 13,240 | |
| | | | | | | | | | | | | |
| Segment expenses: | | | | | | | | | | | | |
| Cost of revenue | | | 3,051 | | | | 7,306 | | | | 10,357 | |
| Selling, general and administrative | | | 527 | | | | 928 | | | | 1,455 | |
| Salaries, wages and payroll taxes | | | 366 | | | | 1,948 | | | | 2,314 | |
| Depreciation and amortization | | | 63 | | | | 75 | | | | 138 | |
| Intangible asset amortization | | | 25 | | | | — | | | | 25 | |
| Total segment expenses | | | 4,032 | | | | 10,257 | | | | 14,289 | |
| Segment operating income (loss) | | $ | 88 | | | $ | (1,137 | ) | | | (1,049 | ) |
| Corporate overhead expenses | | | | | | | | | | | 780 | |
| Non-operating income | | | | | | | | | | | (71 | ) |
| Loss before income taxes | | | | | | | | | | | (1,758 | ) |
| Income taxes | | | | | | | | | | | (31 | ) |
| Net loss | | | | | | | | | | $ | (1,789 | ) |
| For the Six Months Ended June 30, 2026 | | e-Commerce Operations | | | Healthcare Operations | | | Total | |
| e-Commerce revenue | | $ | 7,277 | | | $ | — | | | $ | 7,277 | |
| Pharmacy prescription and other revenue, net of PBM fees | | | — | | | | 10,348 | | | | 10,348 | |
| Pharmacy contract revenue | | | — | | | | 4,111 | | | | 4,111 | |
| Revenues, net | | | 7,277 | | | | 14,459 | | | | 21,736 | |
| | | | | | | | | | | | | |
| Segment expenses: | | | | | | | | | | | | |
| Cost of revenue | | | 5,391 | | | | 8,239 | | | | 13,630 | |
| Selling, general and administrative | | | 974 | | | | 1,883 | | | | 2,857 | |
| Salaries, wages and payroll taxes | | | 720 | | | | 3,225 | | | | 3,945 | |
| Depreciation and amortization | | | 25 | | | | 78 | | | | 103 | |
| Intangible asset amortization | | | 51 | | | | — | | | | 51 | |
| Total segment expenses | | | 7,161 | | | | 13,425 | | | | 20,586 | |
| Segment operating income | | $ | 116 | | | $ | 1,034 | | | | 1,150 | |
| Corporate overhead expenses | | | | | | | | | | | 2,380 | |
| Non-operating income | | | | | | | | | | | (2 | ) |
| Loss before income taxes | | | | | | | | | | | (1,228 | ) |
| Income taxes | | | | | | | | | | | (48 | ) |
| Net loss | | | | | | | | | | $ | (1,276 | ) |
| For the Six Months Ended June 30, 2025 | | e-Commerce Operations | | | Healthcare Operations | | | Total | |
| e-Commerce revenue | | $ | 7,126 | | | $ | — | | | $ | 7,126 | |
| Pharmacy prescription and other revenue, net of PBM fees | | | — | | | | 17,664 | | | | 17,664 | |
| Pharmacy contract revenue | | | — | | | | 2,376 | | | | 2,376 | |
| Revenues, net | | | 7,126 | | | | 20,040 | | | | 27,166 | |
| | | | | | | | | | | | | |
| Segment expenses: | | | | | | | | | | | | |
| Cost of revenue | | | 5,332 | | | | 16,087 | | | | 21,419 | |
| Selling, general and administrative | | | 982 | | | | 1,847 | | | | 2,829 | |
| Salaries, wages and payroll taxes | | | 701 | | | | 4,027 | | | | 4,728 | |
| Depreciation and amortization | | | 127 | | | | 163 | | | | 290 | |
| Intangible asset amortization | | | 51 | | | | — | | | | 51 | |
| Total segment expenses | | | 7,193 | | | | 22,124 | | | | 29,317 | |
| Segment operating loss | | $ | (67 | ) | | $ | (2,084 | ) | | | (2,151 | ) |
| Corporate overhead expenses | | | | | | | | | | | 1,762 | |
| Non-operating income | | | | | | | | | | | (222 | ) |
| Loss before income taxes | | | | | | | | | | | (3,691 | ) |
| Income taxes | | | | | | | | | | | (40 | ) |
| Net loss | | | | | | | | | | $ | (3,731 | ) |
| | | e-Commerce Operations | | | Healthcare Operations | | | Total | |
| Total assets as of June 30, 2026 | | $ | 14,230 | | | $ | 14,442 | | | $ | 28,672 | |
| | | | | | | | | | | | | |
| Total assets as of December 31, 2025 | | $ | 12,748 | | | $ | 14,717 | | | $ | 27,465 | |
|